Compositions comprising ONCONASE (TM) and STELAZINE (TM) or TAMOXIFEN (TM)
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 30, 1996
Issued Date -
N/A
app pub date -
Aug 1, 1994
filing date -
Apr 6, 1988
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A pharmaceutical to be sold under the ONCONASE trademark, as described in pending commonly owned application application Ser. No. 07/436,141 filed Nov. 13, 1989 is combined with other drugs sold under the trademarks TAMOXIFEN and STELAZINE. The combination of ONCONASE with TAMOXIFEN has unexpected bioactivity in vitro against ASPC-1 human pancreatic adenocarcinoma cells and the combination of ONCONASE with STELAZINE has unexpected bioactivity in vitro against A-549 human lung carcinoma cells.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully